UnitedHealth is currently grappling with several serious challenges that have led to a steep decline in its stock value. The most pressing issue is a criminal investigation by the U.S. Department of Justice into alleged improper billing practices related to Medicare, as reported by Reuters. This investigation has contributed to increasing investor anxiety, prompting shares to fall nearly 7%.
Adding to the turmoil, UnitedHealth’s CEO Andrew Witty has resigned due to personal reasons. In his place, former CEO and current chairman Stephen Hemsley has stepped back into the CEO role. Compounding the situation is a significant cybersecurity breach that compromised the data of over 190 million individuals, leading to an anticipated financial hit of $2.9 billion, according to a report from Cinco Días.
In response to these multifaceted challenges, UnitedHealth has revised its financial outlook for 2025, reducing its earnings forecast to $26–$26.50 per share from the previous $29.50–$30 target due to rising medical costs and other operational issues. CBS News noted this revision aligns with a 22% decline in the company's stock following the announcement, reflecting the ongoing challenges faced by UnitedHealth in maintaining its market position and investor confidence.